✦ LIBER ✦

Characterisation of the roles of ABCB1, ABCC1, ABCC2 and ABCG2 in the transport and pharmacokinetics of actinomycin D in vitro and in vivo

✍ Scribed by Christopher R. Hill; David Jamieson; Huw D. Thomas; Colin D.A. Brown; Alan V. Boddy; Gareth J. Veal

Book ID: 119194855
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 988 KB
Volume: 85
Category: Article
ISSN: 0006-2952
DOI: 10.1016/j.bcp.2012.10.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

0121 Haplotype analysis in ABC transport

0121 Haplotype analysis in ABC transporter genes and association of genetic variation in ABCB1, ABCC1, ABCC2, ABCC5 and ABCB4 with epilepsy outcome

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 253 KB

Variation and evolution of the ABC trans

Variation and evolution of the ABC transporter genes ABCB1, ABCC1, ABCG2, ABCG5 and ABCG8: implication for pharmacogenetics and disease

✍ Silverton, Latoya; Dean, Michael; Moitra, Karobi 📂 Article 📅 2011 🏛 Walter de Gruyter GmbH & Co. KG 🌐 English ⚖ 364 KB

Expression of the drug transporters MDR1

Expression of the drug transporters MDR1/ABCB1, MRP1/ABCC1, MRP2/ABCC2, BCRP/ABCG2, and PXR in peripheral blood mononuclear cells and their relationship with the expression in intestine and liver

✍ Nadine Albermann; Friedrich Hubertus Schmitz-Winnenthal; Kaspar Z’graggen; Chris 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 374 KB

A comprehensive study of polymorphisms i

A comprehensive study of polymorphisms in the ABCB1, ABCC2, ABCG2, NR1I2 genes and lymphoma risk

✍ Daniele Campa; Katja Butterbach; Susan L. Slager; Christine F. Skibola; Silvia d 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 French ⚖ 450 KB

Expression and activity of the efflux tr

Expression and activity of the efflux transporters ABCB1, ABCC2 and ABCG2 in the human colorectal carcinoma cell line LS513

✍ Laurent Salphati; Emile G. Plise; Guangmin Li 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 826 KB

Individual and combined roles of CYP3A,

Individual and combined roles of CYP3A, P-glycoprotein (MDR1/ABCB1) and MRP2 (ABCC2) in the pharmacokinetics of docetaxel

✍ Robert A.B. van Waterschoot; Jurjen S. Lagas; Els Wagenaar; Hilde Rosing; Jos H. 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 181 KB

## Abstract Docetaxel is one of the most widely used anticancer drugs. A major problem with docetaxel treatment, however, is the considerable interpatient variability in docetaxel exposure. Another disadvantage of the drug is that it has a very low oral bioavailability and can, therefore, only be a